Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects

Fodor, Decebal; Suciu, Bogdan Andrei; Jung, Ioan; Gurzu, Simona; Sipos, Tamas-Csaba; Doros, Attila; Kobori, Laszlo

Decebal Fodor, Bogdan Andrei Suciu, Ioan Jung, Simona Gurzu, Tamas-Csaba Sipos, Attila Doros, Laszlo Kobori

Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects

Abstract:
Hepatocellurar carcinoma (HCC) is the most frequent primary hepatic tumor, the vast majority of patients have less than a 12 month survival rate. The aim of this study was to evaluate the efficacy of TACE in patients with HCC, based on a case series and literature review. The study included 12 consecutive patients with HCC who underwent surgical treatment (resection, liver transplantation ± resection) at the Department of Transplantation and Surgery, Semmelweis University, Budapest, during 2009-2015. All the patients received at least one TACE session. Patients with BCLC B-stage who benefit from TACE and another alternative therapy (eg, RFA) may be associated with or exhibit tumor stagnation, or tumor necrosis in most cases. In C BCLC stages, desperate cases - the two patients to whom TACE was the last therapeutic attitude, despite the predicted prognosis, TACE assured the prolongation of life and increased life quality. In the majority of patients in this study, stage A BCLC, chemoembolization was a therapeutic attitude that allowed subsequent liver transplantation (when it was not feasible initially due to tumor size) or liver resection in apparently inoperable cases. The arterial chemotherapy is the unanimously accepted indication in patients with stage B, BCLC. The data presented encourages us to opt for TACE with the intention of destaging BCLC and giving an operability character to the hepatic tumors (resection ± hepatic transplantation). In stage C BCLC, TACE can be a last attempt to improve the quality of life and to control tumor progression.

Keywords:
hepatocellular carcinoma; transarterial chemoembolization; liver transplantation; liver resection

Issue: 2019 Volume 56, Issue 1

Pages: 194-187

Publication date: 2019/3/30

https://doi.org/10.37358/MP.19.1.5150

Download Pdf Article

This article is published under the Creative Commons Attribution 4.0 International License

Citation Styles

Cite this article as:
FODOR, D., SUCIU, B.A., JUNG, I., GURZU, S., SIPOS, T., DOROS, A., KOBORI, L., Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects, Mater. Plast., 56(1), 2019, 194-187. https://doi.org/10.37358/MP.19.1.5150

Vancouver
Fodor D, Suciu BA, Jung I, Gurzu S, Sipos T, Doros A, Kobori L. Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects. Mater. Plast.[internet]. 2019 Jan;56(1):194-187. Available from: https://doi.org/10.37358/MP.19.1.5150

APA 6th edition
Fodor, D., Suciu, B.A., Jung, I., Gurzu, S., Sipos, T., Doros, A. & Kobori, L. (2019). Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects. Materiale Plastice, 56(1), 194-187. https://doi.org/10.37358/MP.19.1.5150

Harvard
Fodor, D., Suciu, B.A., Jung, I., Gurzu, S., Sipos, T., Doros, A., Kobori, L. (2019). 'Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects', Materiale Plastice, 56(1), pp. 194-187. https://doi.org/10.37358/MP.19.1.5150

IEEE
D. Fodor, B.A. Suciu, I. Jung, S. Gurzu, T. Sipos, A. Doros, L. Kobori, "Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects". Materiale Plastice, vol. 56, no. 1, pp. 194-187, 2019. [online]. https://doi.org/10.37358/MP.19.1.5150

Text
Decebal Fodor, Bogdan Andrei Suciu, Ioan Jung, Simona Gurzu, Tamas-Csaba Sipos, Attila Doros, Laszlo Kobori,
Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects,
Materiale Plastice,
Volume 56, Issue 1,
2019,
Pages 194-187,
ISSN 2668-8220,
https://doi.org/10.37358/MP.19.1.5150.
(https://revmaterialeplastice.ro/Articles.asp?ID=5150)
Keywords: hepatocellular carcinoma; transarterial chemoembolization; liver transplantation; liver resection

RIS
TY - JOUR
T1 - Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects
A1 - Fodor, Decebal
A2 - Suciu, Bogdan Andrei
A3 - Jung, Ioan
A4 - Gurzu, Simona
A5 - Sipos, Tamas-Csaba
A6 - Doros, Attila
A7 - Kobori, Laszlo
JF - Materiale Plastice
JO - Mater. Plast.
PB - Materiale Plastice SRL
SN - 2668-8220
Y1 - 2019
VL - 56
IS - 1
SP - 194
EP - 187
UR - https://doi.org/10.37358/MP.19.1.5150
KW - hepatocellular carcinoma
KW - transarterial chemoembolization
KW - liver transplantation
KW - liver resection
ER -

BibTex
@article{MatPlast2019P194,
author = {Fodor Decebal and Suciu Bogdan Andrei and Jung Ioan and Gurzu Simona and Sipos Tamas-Csaba and Doros Attila and Kobori Laszlo},
title = {Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects},
journal = {Materiale Plastice},
volume = {56},
number = {1},
pages = {194-187},
year = {2019},
issn = {2668-8220},
doi = {https://doi.org/10.37358/MP.19.1.5150},
url = {https://revmaterialeplastice.ro/Articles.asp?ID=5150}
}

Downloads number: 0

<<<< back

PUBLISHING SECTION

Author Guidelines

* Paper Drafting

* Paper Template (doc)

* Ethical Statement (doc)

* Paper Submission

* Author Payments

Ghidul Autorului (ro)

Submit Paper

Author's Page